Bank1 modulates the differentiation and molecular profile of key B cell populations in autoimmunity.

Adaptive immunity Autoimmune diseases Autoimmunity Genetics Mouse models

Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
20 Aug 2024
Historique:
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 20 8 2024
Statut: aheadofprint

Résumé

This study aimed at defining the role of the B-cell adaptor protein BANK1 in the appearance of age-associated B cells (ABCs) in two SLE mouse models (TLR7.tg6 and Imiquimod-induced mice), crossed with Bank1-/- mice. The absence of Bank1 led to a significant reduction in ABC levels, also affecting other B cell populations. To gain deeper insights into their differentiation pathway and the impact of Bank1 on B cell populations, a single-cell transcriptome assay was performed. In the TLR7.tg6 model, we identified 10 clusters within B cells, including an ABC-specific cluster which was decreased in Bank1-deficient mice. In its absence, ABCs exhibited an anti-inflammatory gene expression profile, while being pro-inflammatory in Bank1-sufficient lupus mice. Trajectory analyses revealed that ABCs originated from marginal zone and memory-like B cells, ultimately acquiring transcriptional characteristics associated with atypical memory cells and long-lived plasma cells. Also, Bank1 deficiency normalized the presence of naïve B cells, which were nearly absent in lupus mice. Interestingly, Bank1 deficiency significantly reduced a distinct cluster containing IFN-responsive genes. These findings underscore the critical role of Bank1 in ABC development, impacting early B cell stages towards ABC differentiation, and the presence of IFN-stimulated gene-containing B cells, both populations determinant for autoimmunity.

Identifiants

pubmed: 39163122
pii: 179417
doi: 10.1172/jci.insight.179417
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gonzalo Gómez Hernández (G)

Department of Medical Genomics, GENyO, Center for Genomics and Oncological Research Pfizer/University of Granada, Granada, Spain.

Daniel Toro-Domínguez (D)

Department of Medical Genomics, GENyO, Center for Genomics and Oncological Research Pfizer/University of Granada, Granada, Spain.

Georgina Galicia (G)

Department of Medical Genomics, GENyO, Center for Genomics and Oncological Research Pfizer/University of Granada, Granada, Spain.

María Morell (M)

Department of Medical Genomics, GENyO, Center for Genomics and Oncological Research Pfizer/University of Granada, Granada, Spain.

Marta E Alarcón-Riquelme (ME)

Department of Medical Genomics, GENyO, Center for Genomics and Oncological Research Pfizer/University of Granada, Granada, Spain.

Classifications MeSH